by
Barbara Kram, Editor | January 02, 2008
The news has not improved for efforts to diagnose ovarian cancer in time for it to be treated. A new study shows that transvaginal ultrasound, which is used along with a blood test, is not reliable. The findings are troubling since the disease is known as a "silent killer" often detected after patients experience symptoms and too late for successful intervention.
The transvaginal ultrasound procedure probes for abnormalities in the ovaries and female reproductive system. The blood test is used to detect CA-125 a protein that is elevated in patients with ovarian cancer. With neither approach shown to be effective in this retrospective study, high-risk patients may need to consider having their ovaries removed to prevent the disease.
The study was conducted by researchers at Birmingham Women's Hospital, UK.
Ad Statistics
Times Displayed: 6173
Times Visited: 20 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
In related news, another marker for the disease is being investigated. For details, go to
the article.
